Literature DB >> 3871364

Modulation of connective tissue metabolism by partially purified human interleukin 1.

H J Richardson, P R Elford, R M Sharrard, J E Meats, R G Russell.   

Abstract

We have investigated the relationship between the monokine interleukin 1 (IL-1) and the connective tissue-stimulating activities produced by monocytes such as mononuclear cell factor (MCF). Using almost exclusively human tissue we have monitored a wide range of MCF-like activities through the partial purification of IL-1 by gel filtration and isoelectric focusing. Activities measured include stimulation of chondrocytes to produce prostaglandins, plasminogen activator and proteoglycanase, enhancement of synovial cell proliferation, and stimulation of cartilage resorption, in addition to IL-1 (lymphocyte activating factor) activity. The activities described show the same molecular heterogeneity; the active material has similar potencies in the different systems, and removal of IL-1 activity by pretreatment with phenylglyoxal also results in loss of the connective tissue-stimulating activities. These results show that the factors responsible for this wide range of activities are very closely related to IL-1 and give further evidence in support of the possible involvement of IL-1 in the processes of joint destruction occurring in chronic inflammatory conditions such as rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871364     DOI: 10.1016/0008-8749(85)90167-4

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Occurrence of interleukin-1 in human synovial fluid: detection by RIA, bioassay and presence of bioassay-inhibiting factors.

Authors:  J B Smith; M H Bocchieri; L Sherbin-Allen; M Borofsky; J L Abruzzo
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

2.  Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria.

Authors:  S Hanazawa; S Amano; K Nakada; Y Ohmori; T Miyoshi; K Hirose; S Kitano
Journal:  Calcif Tissue Int       Date:  1987-07       Impact factor: 4.333

3.  Colony stimulating factor occurs in both inflammatory and noninflammatory synovial fluids.

Authors:  J B Smith; M H Bocchieri; J B Smith; L Sherbin-Allen; J L Abruzzo
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

4.  The effect of calcium channel blockers and calmodulin inhibitors on the macrophage factor-stimulated synthesis of collagenase by rabbit chondrocytes.

Authors:  J C Nolan; C E Gathright; L E Wagner
Journal:  Agents Actions       Date:  1988-08

5.  Isothiazolones interfere with normal matrix metalloproteinase activation and inhibit cartilage proteoglycan degradation.

Authors:  E C Arner; M A Pratta; B Freimark; M Lischwe; J M Trzaskos; R L Magolda; S W Wright
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1.

Authors:  S J Hopkins; M Humphreys; M I Jayson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

7.  Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.

Authors:  R J Smith; N A Rohloff; L M Sam; J M Justen; M R Deibel; J C Cornette
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

8.  Identification of the major fibroblast growth factors released spontaneously in inflammatory arthritis as platelet derived growth factor and tumour necrosis factor-alpha.

Authors:  S C Thornton; S B Por; R Penny; M Richter; L Shelley; S N Breit
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

9.  Interleukin 1 in Crohn's disease.

Authors:  J Satsangi; R A Wolstencroft; J Cason; C C Ainley; D C Dumonde; R P Thompson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

10.  Bone resorbing activity in synovial fluids in destructive osteoarthritis and rheumatoid arthritis.

Authors:  W H Alwan; P A Dieppe; C J Elson; J W Bradfield
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.